|
2025-04-14 |
2025-04-11 |
S
Sale
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Officer
|
1,000
-0.1%
13.14
USD 631
|
1,000
-0.1%
|
13.14
|
USD 100,000
|
|
|
2025-02-12 |
2025-02-12 |
PS
Planned sale
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Officer
|
5,200
-5.0%
23.53
USD 122,356
|
5,200
-5.0%
|
23.53
|
USD 122,356
|
|
|
2025-02-12 |
2025-02-12 |
PS
Planned sale
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Officer
|
8,000
-8.2%
23.53
USD 188,240
|
8,000
-8.2%
|
23.53
|
USD 188,240
|
|
|
2025-02-12 |
2025-02-12 |
S
Sale
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Officer
|
2,568
-2.0%
23.53
USD 60,426
|
2,568
-2.0%
|
23.53
|
USD 60,426
|
|
|
2025-02-12 |
2025-02-12 |
S
Sale
|
Inrig Jula
CHIEF MEDICAL OFFICER
Officer
|
2,568
-2.8%
23.53
USD 60,426
|
2,568
-2.8%
|
23.53
|
USD 60,426
|
|
|
2025-02-12 |
2025-02-11 |
PS
Planned sale
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Officer
|
9,244
-14.5%
25.00
USD 231,100
|
9,244
-14.5%
|
25.00
|
USD 231,100
|
|
|
2025-02-12 |
2025-02-11 |
PS
Planned sale
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Officer
|
15,000
-19.1%
25.00
USD 375,000
|
15,000
-19.1%
|
25.00
|
USD 375,000
|
|
|
2025-02-12 |
2025-02-11 |
PS
Planned sale
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Officer
|
10,000
-13.6%
25.00
USD 250,000
|
10,000
-13.6%
|
25.00
|
USD 250,000
|
|
|
2025-02-12 |
2025-02-11 |
PS
Planned sale
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Officer
|
10,000
-13.6%
25.00
USD 250,000
|
10,000
-13.6%
|
25.00
|
USD 250,000
|
|
|
2025-02-12 |
2025-02-11 |
PS
Planned sale
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Officer
|
10,000
-13.6%
25.00
USD 250,000
|
10,000
-13.6%
|
25.00
|
USD 250,000
|
|
|
2025-02-12 |
2025-02-11 |
PS
Planned sale
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Officer
|
3,074
-2.4%
25.00
USD 76,850
|
3,074
-2.4%
|
25.00
|
USD 76,850
|
|
|
2025-02-12 |
2025-02-11 |
PS
Planned sale
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Executive Director
|
11,375
-2.6%
24.04
USD 273,455
|
11,375
-2.6%
|
24.04
|
USD 273,455
|
|
|
2025-02-10 |
2025-02-06 |
PS
Planned sale
|
Baynes Roy D.
Non-Executive Director
|
10,000
-24.4%
22.00
USD 220,000
|
10,000
-24.4%
|
22.00
|
USD 220,000
|
|
|
2025-02-04 |
2025-02-04 |
PS
Planned sale
|
Inrig Jula
CHIEF MEDICAL OFFICER
Officer
|
1,066
-1.3%
20.11
USD 21,437
|
1,066
-1.3%
|
20.11
|
USD 21,437
|
|
|
2025-02-04 |
2025-02-03 |
PS
Planned sale
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Officer
|
8,951
-9.1%
19.78
USD 177,051
|
8,951
-9.1%
|
19.78
|
USD 177,051
|
|
|
2025-02-04 |
2025-02-03 |
PS
Planned sale
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Executive Director
|
50,691
-10.5%
20.21
USD 1,024,343
|
50,691
-10.5%
|
20.21
|
USD 1,024,343
|
|
|
2025-02-04 |
2025-02-03 |
PS
Planned sale
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Officer
|
8,951
-8.6%
19.78
USD 177,051
|
8,951
-8.6%
|
19.78
|
USD 177,051
|
|
|
2025-02-04 |
2025-02-03 |
S
Sale
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Officer
|
3,348
-5.0%
20.12
USD 67,362
|
3,348
-5.0%
|
20.12
|
USD 67,362
|
|
|
2025-02-04 |
2025-02-03 |
S
Sale
|
Inrig Jula
CHIEF MEDICAL OFFICER
Officer
|
4,207
-4.7%
20.12
USD 84,645
|
4,207
-4.7%
|
20.12
|
USD 84,645
|
|
|
2025-02-04 |
2025-02-03 |
S
Sale
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Officer
|
5,166
-4.0%
20.12
USD 103,940
|
5,166
-4.0%
|
20.12
|
USD 103,940
|
|
|
2025-02-04 |
2025-02-03 |
S
Sale
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Officer
|
5,192
-5.5%
20.12
USD 104,463
|
5,192
-5.5%
|
20.12
|
USD 104,463
|
|
|
2025-01-23 |
2025-01-23 |
PS
Planned sale
|
Baynes Roy D.
Non-Executive Director
|
16,000
-34.0%
20.00
USD 320,000
|
16,000
-34.0%
|
20.00
|
USD 320,000
|
|
|
2025-01-23 |
2025-01-22 |
PS
Planned sale
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Officer
|
2,437
-2.8%
19.46
USD 47,424
|
2,437
-2.8%
|
19.46
|
USD 47,424
|
|
|
2025-01-23 |
2025-01-22 |
PS
Planned sale
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Executive Director
|
10,736
-3.0%
19.46
USD 208,923
|
10,736
-3.0%
|
19.46
|
USD 208,923
|
|
|
2025-01-23 |
2025-01-22 |
S
Sale
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Officer
|
925
-1.7%
18.94
USD 17,520
|
925
-1.7%
|
18.94
|
USD 17,520
|
|
|
2025-01-23 |
2025-01-22 |
PS
Planned sale
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Officer
|
2,437
-3.1%
19.46
USD 47,424
|
2,437
-3.1%
|
19.46
|
USD 47,424
|
|
|
2025-01-23 |
2025-01-22 |
S
Sale
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Officer
|
865
-1.2%
18.94
USD 16,384
|
865
-1.2%
|
18.94
|
USD 16,384
|
|
|
2025-01-23 |
2025-01-22 |
S
Sale
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Officer
|
1,584
-1.5%
18.94
USD 30,002
|
1,584
-1.5%
|
18.94
|
USD 30,002
|
|
|
2025-01-06 |
2025-01-06 |
PS
Planned sale
|
Inrig Jula
CHIEF MEDICAL OFFICER
Officer
|
440
-0.7%
18.76
USD 8,254
|
440
-0.7%
|
18.76
|
USD 8,254
|
|
|
2025-01-06 |
2025-01-03 |
S
Sale
|
Inrig Jula
CHIEF MEDICAL OFFICER
Officer
|
2,066
-3.3%
19.10
USD 39,461
|
2,066
-3.3%
|
19.10
|
USD 39,461
|
|
|
2024-12-27 |
2024-12-26 |
PS
Planned sale
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Officer
|
15,000
-21.5%
17.22
USD 258,278
|
15,000
-21.5%
|
17.22
|
USD 258,278
|
|
|
2024-11-25 |
2024-11-25 |
S
Sale
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Officer
|
12,090
-18.0%
18.30
USD 221,258
|
12,090
-18.0%
|
18.30
|
USD 221,258
|
|
|
2024-10-04 |
2024-10-04 |
PS
Planned sale
|
LYONS GARY A
Non-Executive Director
|
18,821
-27.0%
15.15
USD 285,227
|
18,821
-27.0%
|
15.15
|
USD 285,227
|
|
|
2024-10-04 |
2024-10-04 |
PS
Planned sale
|
LYONS GARY A
Non-Executive Director
|
21,179
-23.3%
14.35
USD 303,874
|
21,179
-23.3%
|
14.35
|
USD 303,874
|
|
|
2024-09-30 |
2024-09-30 |
PS
Planned sale
|
Meckler Jeffrey A
Non-Executive Director
|
40,000
-33.1%
14.06
USD 562,324
|
40,000
-33.1%
|
14.06
|
USD 562,324
|
|
|
2024-09-10 |
2024-09-10 |
PS
Planned sale
|
Inrig Jula
CHIEF MEDICAL OFFICER
Officer
|
684
-1.1%
12.98
USD 8,878
|
684
-1.1%
|
12.98
|
USD 8,878
|
|
|
2024-09-09 |
2024-09-09 |
PS
Planned sale
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Officer
|
4,387
-5.3%
11.52
USD 50,538
|
4,387
-5.3%
|
11.52
|
USD 50,538
|
|
|
2024-09-09 |
2024-09-09 |
S
Sale
|
Inrig Jula
CHIEF MEDICAL OFFICER
Officer
|
2,191
-3.4%
11.52
USD 25,240
|
2,191
-3.4%
|
11.52
|
USD 25,240
|
|
|
2024-09-09 |
2024-09-09 |
PS
Planned sale
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Executive Director
|
21,125
-5.5%
11.52
USD 243,360
|
21,125
-5.5%
|
11.52
|
USD 243,360
|
|
|
2024-09-09 |
2024-09-09 |
S
Sale
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Officer
|
2,191
-2.0%
11.52
USD 25,240
|
2,191
-2.0%
|
11.52
|
USD 25,240
|
|
|
2024-09-09 |
2024-09-09 |
PS
Planned sale
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Officer
|
4,387
-4.9%
11.52
USD 50,538
|
4,387
-4.9%
|
11.52
|
USD 50,538
|
|
|
2024-09-09 |
2024-09-09 |
S
Sale
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Officer
|
2,490
-3.2%
11.52
USD 28,685
|
2,490
-3.2%
|
11.52
|
USD 28,685
|
|
|
2024-09-05 |
2024-09-04 |
S
Sale
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Officer
|
514
-0.7%
9.51
USD 4,888
|
514
-0.7%
|
9.51
|
USD 4,888
|
|
|
2024-04-12 |
2024-04-11 |
S
Sale
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Officer
|
54
-0.1%
6.74
USD 364
|
54
-0.1%
|
6.74
|
USD 364
|
|
|
2024-02-02 |
2024-02-01 |
PS
Planned sale
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Officer
|
2,590
-3.1%
8.86
USD 22,947
|
2,590
-3.1%
|
8.86
|
USD 22,947
|
|
|
2024-02-02 |
2024-02-01 |
S
Sale
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Officer
|
2,174
-2.5%
8.53
USD 18,548
|
2,174
-2.5%
|
8.53
|
USD 18,548
|
|
|
2024-02-02 |
2024-02-01 |
S
Sale
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Officer
|
4,195
-4.0%
8.53
USD 35,789
|
4,195
-4.0%
|
8.53
|
USD 35,789
|
|
|
2024-02-02 |
2024-02-01 |
S
Sale
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Officer
|
3,818
-5.1%
8.53
USD 32,573
|
3,818
-5.1%
|
8.53
|
USD 32,573
|
|
|
2024-02-02 |
2024-02-01 |
PS
Planned sale
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Officer
|
2,590
-3.3%
8.86
USD 22,947
|
2,590
-3.3%
|
8.86
|
USD 22,947
|
|
|
2024-02-02 |
2024-02-01 |
S
Sale
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Officer
|
2,174
-2.7%
8.53
USD 18,548
|
2,174
-2.7%
|
8.53
|
USD 18,548
|
|
|
2024-02-02 |
2024-02-01 |
S
Sale
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Officer
|
2,820
-5.1%
8.53
USD 24,058
|
2,820
-5.1%
|
8.53
|
USD 24,058
|
|
|
2024-02-02 |
2024-02-01 |
PS
Planned sale
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Executive Director
|
10,016
-2.8%
8.86
USD 88,742
|
10,016
-2.8%
|
8.86
|
USD 88,742
|
|
|
2024-02-02 |
2024-02-01 |
S
Sale
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Executive Director
|
9,106
-2.5%
8.53
USD 77,693
|
9,106
-2.5%
|
8.53
|
USD 77,693
|
|
|
2024-02-02 |
2024-02-01 |
S
Sale
|
Inrig Jula
CHIEF MEDICAL OFFICER
Officer
|
2,174
-3.6%
8.53
USD 18,547
|
2,174
-3.6%
|
8.53
|
USD 18,547
|
|
|
2024-01-25 |
2024-01-23 |
PS
Planned sale
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Officer
|
2,062
-3.3%
8.96
USD 18,476
|
2,062
-3.3%
|
8.96
|
USD 18,476
|
|
|
2024-01-25 |
2024-01-23 |
PS
Planned sale
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Executive Director
|
7,873
-3.2%
8.96
USD 70,542
|
7,873
-3.2%
|
8.96
|
USD 70,542
|
|
|
2024-01-25 |
2024-01-23 |
PS
Planned sale
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Officer
|
2,062
-3.5%
8.96
USD 18,476
|
2,062
-3.5%
|
8.96
|
USD 18,476
|
|
|
2024-01-25 |
2024-01-23 |
S
Sale
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Officer
|
853
-1.7%
9.07
USD 7,735
|
853
-1.7%
|
9.07
|
USD 7,735
|
|
|
2024-01-25 |
2024-01-23 |
S
Sale
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Officer
|
1,559
-1.9%
9.07
USD 14,138
|
1,559
-1.9%
|
9.07
|
USD 14,138
|
|
|
2024-01-25 |
2024-01-23 |
S
Sale
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Officer
|
910
-2.2%
9.07
USD 8,252
|
910
-2.2%
|
9.07
|
USD 8,252
|
|
|
2024-01-05 |
2024-01-04 |
PS
Planned sale
|
Inrig Jula
Chief Medical Officer
Officer
|
440
-1.2%
9.17
USD 4,035
|
440
-1.2%
|
9.17
|
USD 4,035
|
|
|
2024-01-05 |
2024-01-03 |
S
Sale
|
Inrig Jula
Chief Medical Officer
Officer
|
2,069
-5.5%
9.48
USD 19,613
|
2,069
-5.5%
|
9.48
|
USD 19,613
|
|
|
2023-10-04 |
2023-10-03 |
S
Sale
|
Heerma Peter
Chief Commercial Officer
Officer
|
3,091
-3.7%
8.25
USD 25,504
|
3,091
-3.7%
|
8.25
|
USD 25,504
|
|
|
2023-09-05 |
2023-09-05 |
PS
Planned sale
|
Dube Eric M
Chief Executive Officer
Executive Director
|
4,455
-1.8%
14.71
USD 65,533
|
4,455
-1.8%
|
14.71
|
USD 65,533
|
|
|
2023-09-05 |
2023-09-05 |
S
Sale
|
Cline Christopher R.
Chief Financial Officer
Officer
|
457
-0.9%
14.71
USD 6,723
|
457
-0.9%
|
14.71
|
USD 6,723
|
|
|
2023-09-05 |
2023-09-05 |
PS
Planned sale
|
ROTE WILLIAM E.
Senior Vice President, R&D
Officer
|
1,815
-2.9%
14.71
USD 26,699
|
1,815
-2.9%
|
14.71
|
USD 26,699
|
|
|
2023-09-05 |
2023-09-05 |
PS
Planned sale
|
REED ELIZABETH E
SVP, GC & Corporate Secretary
Officer
|
1,815
-3.0%
14.71
USD 26,699
|
1,815
-3.0%
|
14.71
|
USD 26,699
|
|
|
2023-05-12 |
2023-05-11 |
PS
Planned sale
|
Calvin Sandra
SVP, Chief Accounting Officer
Officer
|
122
-0.3%
16.12
USD 1,967
|
122
-0.3%
|
16.12
|
USD 1,967
|
|
|
2023-05-12 |
2023-05-10 |
PS
Planned sale
|
ROTE WILLIAM E.
Senior Vice President, R&D
Officer
|
825
-1.4%
16.59
USD 13,687
|
825
-1.4%
|
16.59
|
USD 13,687
|
|
|
2023-05-12 |
2023-05-10 |
S
Sale
|
Cline Christopher R.
Chief Financial Officer
Officer
|
455
-0.9%
16.59
USD 7,548
|
455
-0.9%
|
16.59
|
USD 7,548
|
|
|
2023-05-12 |
2023-05-10 |
PS
Planned sale
|
REED ELIZABETH E
SVP, GC & Corporate Secretary
Officer
|
825
-1.4%
16.59
USD 13,687
|
825
-1.4%
|
16.59
|
USD 13,687
|
|
|
2023-05-12 |
2023-05-10 |
S
Sale
|
Calvin Sandra
SVP, Chief Accounting Officer
Officer
|
436
-1.0%
16.59
USD 7,233
|
436
-1.0%
|
16.59
|
USD 7,233
|
|
|
2023-04-13 |
2023-04-11 |
S
Sale
|
Cline Christopher R.
Chief Financial Officer
Officer
|
47
-0.1%
21.49
USD 1,010
|
47
-0.1%
|
21.49
|
USD 1,010
|
|
|
2023-02-02 |
2023-02-02 |
PS
Planned sale
|
Calvin Sandra
SVP, Chief Accounting Officer
Officer
|
360
-0.8%
22.42
USD 8,071
|
360
-0.8%
|
22.42
|
USD 8,071
|
|
|
2023-02-02 |
2023-02-01 |
PS
Planned sale
|
Dube Eric M
Chief Executive Officer
Executive Director
|
8,196
-3.3%
22.25
USD 182,361
|
8,196
-3.3%
|
22.25
|
USD 182,361
|
|
